Novanta announces $300 million private placement to institutional investors

Novanta Inc. entered into a securities purchase agreement for a private placement expected to generate approximately $300 million in gross proceeds before fees and expenses, the company announced.

Under the agreement, institutional and accredited investors will purchase 2,142,857 common shares at $140.00 per share. The private placement is scheduled to close on or about June 11, 2026, subject to customary closing conditions.

The shares are being sold in a transaction not involving a public offering and have not been registered under the Securities Act of 1933. The shares may not be reoffered or resold in the United States except through an effective registration statement or applicable exemption from registration requirements.

Novanta and the investors also executed a registration rights agreement requiring the company to register the resale of the common shares sold in the private placement.

The information is based on a company press release statement.

You May Also Be Interested In

• MoonLake prices $200 million public offering at $20 per share
• Verastem reports early trial data for KRAS G12D cancer drug VS-7375
• YZi Labs ends proxy fight with CEA Industries in board deal